Patents by Inventor Oscar Huertas Gambín

Oscar Huertas Gambín has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sustained release compositions comprising micronized tolcapone
    Patent number: 11883538
    Abstract: The present invention relates to sustained release tablet comprising micronized tolcapone, a release retardant and a binder, to said tablet for use in the prevention and/or treatment of a transthyretin-associated amyloidosis, to a method for the prevention and/or treatment of a transthyretin-associated amyloidosis comprising administering to a subject in need thereof an effective amount of said tablet, to pharmaceutical composition in the form of said tablet which is used in the prevention and/or treatment of a transthyretin-associated amyloidosis and to a process for the manufacture of said tablet.
    Type: Grant
    Filed: July 28, 2017
    Date of Patent: January 30, 2024
    Assignee: Som Innovation Biotech, S.L.
    Inventors: Anna Nardi Ricart, Josep María Suñé Negre, Núria Reig Bolaño, Raúl Insa Boronat, Oscar Huertas Gambín, Santiago Esteva Gras, Gal⋅Ia Pericot Mohr
  • COMPOUNDS FOR USE IN THE TREATMENT OF SYNUCLEINOPATHIES
    Publication number: 20230147129
    Abstract: The present invention relates to a compound selected from the group consisting of of N-[(2S)-1-amino-3-(3-fluorophenyl)propan-2-yl]-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)thiophene-2-carboxamide, [2-(2,6-dichloroanilino)-4,5-dihydroimidazol-1-yl]-phenylmethanone, 2-amino-5-bromo-4-phenyl-1H-pyrimidin-6-one, N-(diaminomethylidene)-2-(2,6-dichlorophenyl)acetamide and 2-(1,4-dioxaspiro[4.5]decan-2-ylmethyl)guanidin, or a pharmaceutically acceptable salt thereof and combinations comprising at least one of said compounds, for use in the treatment and/or prevention of synucleinopathies.
    Type: Application
    Filed: March 26, 2021
    Publication date: May 11, 2023
    Inventors: Raúl INSA BORONAT, Núria REIG BOLAÑO, Luca SIGNORILE, Oscar HUERTAS GAMBÍN, Salvador VENTURA ZAMORA, Samuel PEÑA DÍAZ
  • TRIAMTERENE OR NOLATREXED FOR USE IN THE TREATMENT OF PHENYLKETONURIA
    Publication number: 20220133726
    Abstract: The present invention relates to a compound selected from the group consisting of nolatrexed, triamterene, sultopride and hydrastinine or a pharmaceutically acceptable salt thereof, preferably triamterene, nolatrexed or a pharmaceutically acceptable salt thereof, and to combination of said compounds with other active ingredients, for use in the treatment and/or prevention of phenylketonuria, to the use of said compound or its combinations in the manufacture of a medicament for the treatment or prevention of said diseases and to a method of treating and/or preventing by administration of said compound or its combinations.
    Type: Application
    Filed: February 13, 2020
    Publication date: May 5, 2022
    Inventors: Raúl INSA BORONAT, Núria REIG BOLAÑO, Aileen FERRÉ FERRÉ, Óscar HUERTAS GAMBÍN, Santiago ESTEVA GRAS, Luca SIGNORILE, Gal.la PERICOT MOHR
  • Sustained Release Compositions Comprising Micronized Tolcapone
    Publication number: 20190167596
    Abstract: The present invention relates to sustained release tablet comprising micronized tolcapone, a release retardant and a binder, to said tablet for use in the prevention and/or treatment of a transthyretin-associated amyloidosis, to a method for the prevention and/or treatment of a transthyretin-associated amyloidosis comprising administering to a subject in need thereof an effective amount of said tablet, to pharmaceutical composition in the form of said tablet which is used in the prevention and/or treatment of a transthyretin-associated amyloidosis and to a process for the manufacture of said tablet.
    Type: Application
    Filed: July 28, 2017
    Publication date: June 6, 2019
    Inventors: Anna Nardi Ricart, Josep María Suñé Negre, Núria Reig Bolaño, Raúl Insa Boronat, Oscar Huertas Gambín, Santiago Esteva Gras, Gal·la Pericot Mohr